1. Synergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cells
   Linda Sooman et al, 2017, BMC Research Notes CrossRef
2. A 3 base pair deletion in TBX1 leads to reduced protein expression and transcriptional activity
   Yuejuan Xu et al, 2017, Scientific Reports CrossRef
3. Proteasome Inhibitor MG132 Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells and Inhibits Tumor Growth
   Farui Sun et al, 2018, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
4. Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors
   Hongsai Chen et al, 2018, EBioMedicine CrossRef
5. Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solution
   Ana C. Henriques et al, 2019, Cancer Letters CrossRef
6. MG132 enhances the radiosensitivity of lung cancer cells in vitro and in vivo
   WEI ZHU et al, 2015, Oncology Reports CrossRef
7. Enzymatic Processing of DNA–Protein Crosslinks
   Maram M. Essawy et al, 2024, Genes CrossRef
8. Gartanin is a novel NEDDylation inhibitor for induction of Skp2 degradation, FBXW2 expression, and autophagy
   Victor Pham et al, 2020, Molecular Carcinogenesis CrossRef
9. Quantification of Intracellular DNA–Protein Cross-Links with N7-Methyl-2′-Deoxyguanosine and Their Contribution to Cytotoxicity
   Tingyu Wen et al, 2024, Chemical Research in Toxicology CrossRef
10. ERK is a negative feedback regulator for IFN-γ/STAT1 signaling by promoting STAT1 ubiquitination
    Ying Zhang et al, 2018, BMC Cancer CrossRef
11. Regulation of aberrant proteasome activity re‐establishes plasticity and long‐term memory in an animal model of Alzheimer's disease
    Kumar Krishna‐K et al, 2020, The FASEB Journal CrossRef
12. Primed for Interactions: Investigating the Primed Substrate Channel of the Proteasome for Improved Molecular Engagement
    Cody A. Loy et al, 2024, Molecules CrossRef
13. Gold Nanoparticles Induced Size Dependent Cytotoxicity on Human Alveolar Adenocarcinoma Cells by Inhibiting the Ubiquitin Proteasome System
    Bashiru Ibrahim et al, 2023, Pharmaceutics CrossRef
14. Cell fate determination in cisplatin resistance and chemosensitization
    Khanh V. Luong et al, 2016, Oncotarget CrossRef
15. NQO1 potentiates apoptosis evasion and upregulates XIAP via inhibiting proteasome-mediated degradation SIRT6 in hepatocellular carcinoma
    Hong-Zhong Zhou et al, 2019, Cell Communication and Signaling CrossRef
16. Live imaging of adult zebrafish cardiomyocyte proliferation ex vivo
    Hessel Honkoop et al, 2021, Development CrossRef
17. Proteasome Inhibitor MG132 is Toxic and Inhibits the Proliferation of Rat Neural Stem Cells but Increases BDNF Expression to Protect Neurons
    Young Min Kim et al, 2020, Biomolecules CrossRef
18. Serratia marcescens‐S3 inhibits Potato virus Y by activating ubiquitination of molecular chaperone proteins NbHsc70‐2 in Nicotiana benthamiana
    Ming Ge et al, 2022, Microbial Biotechnology CrossRef
19. Effect of cisplatin on proteasome activity
    G.R. Tundo et al, 2015, Journal of Inorganic Biochemistry CrossRef
20. Positioning of proteasome inhibitors in therapy of solid malignancies
    Margot S. F. Roeten et al, 2018, Cancer Chemotherapy and Pharmacology CrossRef
21. Proteasome inhibitor MG132 enhances the sensitivity of human OSCC cells to cisplatin via a ROS/DNA damage/p53 axis
    Zheng Zheng et al, 2023, Experimental and Therapeutic Medicine CrossRef